Red Hat AI 3.5 tackles the GPU queue that can stall AI pilots31m ago A Candid Abacus AI Review: The All-in-One AI Platform for Professionals & Enterprises32m ago Governments are turning to Claude to automate spying32m ago CNN Just Ran One of the Worst AI Puff Pieces We’ve Ever Seen in Our Lives About That “AI Actor” Tilly Northwood44m ago How Credit Genie keeps codebase docs fresh with OpenWiki45m ago Closing The Gap Between AI Ambition And Data Reality47m ago Universal Music is launching an AI music platform with ElevenLabs53m ago Top Pentagon Official Rejects Anthropic Researcher’s AI Warning2h ago Arlequin AI raises €28M to build novel AI models that learn complex relationships at scale57m ago SpaceX sues to block release of tax-break records for its Texas Terafab project57m ago Salesforce closes Fin and eyes $2bn Listen Labs, Business Insider reports58m ago Google brings Gemini for desktop app to Windows59m ago AI’s Hidden Apprenticeship Tax (And How Firms Can Avoid It)1h ago Abacus.AI Releases Three Open-Weight Smaug Models for Agentic Workloads1h ago

Red Hat AI 3.5 tackles the GPU queue that can stall AI pilots31m ago A Candid Abacus AI Review: The All-in-One AI Platform for Professionals & Enterprises32m ago Governments are turning to Claude to automate spying32m ago CNN Just Ran One of the Worst AI Puff Pieces We’ve Ever Seen in Our Lives About That “AI Actor” Tilly Northwood44m ago How Credit Genie keeps codebase docs fresh with OpenWiki45m ago Closing The Gap Between AI Ambition And Data Reality47m ago Universal Music is launching an AI music platform with ElevenLabs53m ago Top Pentagon Official Rejects Anthropic Researcher’s AI Warning2h ago Arlequin AI raises €28M to build novel AI models that learn complex relationships at scale57m ago SpaceX sues to block release of tax-break records for its Texas Terafab project57m ago Salesforce closes Fin and eyes $2bn Listen Labs, Business Insider reports58m ago Google brings Gemini for desktop app to Windows59m ago AI’s Hidden Apprenticeship Tax (And How Firms Can Avoid It)1h ago Abacus.AI Releases Three Open-Weight Smaug Models for Agentic Workloads1h ago

Laigo Bio closes €17M seed to advance SureTACs

The Next WebPublished Mar 27, 2026

Laigo Bio has secured €17 million in seed funding to develop its SureTACs technology, aiming to advance targeted cancer therapies. The investment will support preclinical development and preparation for clinical trials.

#laigo-bio #seed-funding #suretacs #targeted-cancer-therapy

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources19h ago

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News2h ago

Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI7h ago